Cancer Research UK logo.
SearchDonate
  • Search

A trial comparing carfilzomib once a week with carfilzomib twice a week for myeloma (ARROW)

Overview

Cancer types:

Myeloma

Status:

Results

Phase:

Phase 3

Details

This trial looked at different ways to have carfilzomib for people with myeloma that had come back or treatment had stopped working.

The trial was open for people to join between 2015 and 2016. The research team published the results in 2018.

Recruitment start: 1 September 2015

Recruitment end: 1 August 2016

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Catherine Williams

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Onyx Pharma

Last reviewed: 06 Jun 2024

CRUK internal database number: 13691

Help and support